Current Methods to Define Metabolic Tumor Volume in Positron Emission Tomography: Which One is Better?

被引：187
作者：
Im H.-J. [1 ,2 ]
Bradshaw T. [1 ]
Solaiyappan M. [3 ]
Cho S.Y. [1 ,3 ,4 ]
机构：
[1] Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, WI
[2] Department of Transdisciplinary Studies, Graduate School of Convergence Science and Technology, Seoul National University, Seoul
[3] Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD
[4] University of Wisconsin Carbone Cancer Center, Madison, WI
来源：
Nuclear Medicine and Molecular Imaging | 2018年 / 52卷 / 1期
基金：
新加坡国家研究基金会;
关键词：
!sup]18[!/sup]F-fluorodeoxyglucose; Metabolic tumor volume; Positron emission tomography; Segmentation; Tumor;
D O I：
10.1007/s13139-017-0493-6
中图分类号：
学科分类号：
摘要：
Numerous methods to segment tumors using 18F-fluorodeoxyglucose positron emission tomography (FDG PET) have been introduced. Metabolic tumor volume (MTV) refers to the metabolically active volume of the tumor segmented using FDG PET, and has been shown to be useful in predicting patient outcome and in assessing treatment response. Also, tumor segmentation using FDG PET has useful applications in radiotherapy treatment planning. Despite extensive research on MTV showing promising results, MTV is not used in standard clinical practice yet, mainly because there is no consensus on the optimal method to segment tumors in FDG PET images. In this review, we discuss currently available methods to measure MTV using FDG PET, and assess the advantages and disadvantages of the methods. © 2017, Korean Society of Nuclear Medicine.
引用
收藏
页码：5 / 15
页数：10
相关论文
共 65 条
  • [61] Park S.Y., Yoon J.K., Park K.J., Lee S.J., Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer, Cancer Imaging, 15, (2015)
  • [62] Burger I.A., Vargas H.A., Apte A., Et al., PET quantification with a histogram derived total activity metric: superior quantitative consistency compared to total lesion glycolysis with absolute or relative SUV thresholds in phantoms and lung cancer patients, Nucl Med Biol, 41, pp. 410-418, (2014)
  • [63] Chen G.H., Yao Z.F., Fan X.W., Et al., Variation in background intensity affects PET-based gross tumor volume delineation in non-small-cell lung cancer: the need for individualized information, Radiother Oncol, 109, pp. 71-76, (2013)
  • [64] Yu J., Li X., Xing L., Et al., Comparison of tumor volumes as determined by pathologic examination and FDG-PET/CT images of non-small-cell lung cancer: a pilot study, Int J Radiat Oncol Biol Phys, 75, pp. 1468-1474, (2009)
  • [65] Laffon E., de Clermont H., Lamare F., Marthan R., Variability of total lesion glycolysis by 18F-FDG-positive tissue thresholding in lung cancer, J Nucl Med Technol, 41, pp. 186-191, (2013)
1234567